<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Cardiology: Interventional &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/cardiology-interventional/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Good long-term survival after catheter valvotomy for pulmonary atresia</title>
		<link>http://www.thedoctorschannel.com/view/good-long-term-survival-after-catheter-valvotomy-for-pulmonary-atresia/</link>
		<pubDate>Mon, 14 May 2012 17:19:50 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[catheter valvotomy]]></category>
		<category><![CDATA[Pulmonary atresia]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31748</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in the April 17th Journal of the American College of Cardiology. PAIVS occurs in 3 to 8 of 100,000 births, and catheter perforation is now an established procedure -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Good long-term survival after catheter valvotomy for pulmonary atresia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Catheter valve perforation for pulmonary atresia with intact ventricular septum (PAIVS) offers good long-term survival with few complications, according to findings published in the April 17th Journal of the American College of Cardiology. PAIVS occurs in 3 to 8 of 100,000 births, and catheter perforation is now an established procedure -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/good-long-term-survival-after-catheter-valvotomy-for-pulmonary-atresia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514drgd002.jpg"/>
	<media:keywords><![CDATA[catheter valvotomy,Pulmonary atresia]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Noninvasive programmed stimulation predicts recurrence of ventricular tachycardia</title>
		<link>http://www.thedoctorschannel.com/view/noninvasive-programmed-stimulation-predicts-recurrence-of-ventricular-tachycardia/</link>
		<pubDate>Mon, 14 May 2012 16:24:41 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[NIPS]]></category>
		<category><![CDATA[Noninvasive programmed stimulation]]></category>
		<category><![CDATA[VT ablation]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31744</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April 24th Journal of the American College of Cardiology. “The recurrence rate following VT ablation in structural heart disease remains substantial and thus better endpoints for VT ablation -]]></description>
		
			<media:content duration="1:50" medium="video">
		<media:title><![CDATA[Noninvasive programmed stimulation predicts recurrence of ventricular tachycardia]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Noninvasive programmed stimulation (NIPS) days after ventricular tachycardia (VT) ablation can predict the risk of recurrence, according to findings published in the April 24th Journal of the American College of Cardiology. “The recurrence rate following VT ablation in structural heart disease remains substantial and thus better endpoints for VT ablation -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/noninvasive-programmed-stimulation-predicts-recurrence-of-ventricular-tachycardia/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514drgd001.jpg"/>
	<media:keywords><![CDATA[NIPS,Noninvasive programmed stimulation,VT ablation]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Quality of life improves after transcatheter aortic valve implantation</title>
		<link>http://www.thedoctorschannel.com/view/quality-of-life-improves-after-transcatheter-aortic-valve-implantation/</link>
		<pubDate>Fri, 11 May 2012 20:57:46 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[TAVI]]></category>
		<category><![CDATA[transcatheter aortic valve implantation]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31701</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Health-related quality of life (HRQOL) improves in the year after transcatheter aortic valve implantation (TAVI), researchers from UK and Germany find in 2 separate studies. “These findings are clinically significant, as improvement in both quality and quantity of life is important to patients and physicians,” Dr. John P. Greenwood from -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Quality of life improves after transcatheter aortic valve implantation]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Health-related quality of life (HRQOL) improves in the year after transcatheter aortic valve implantation (TAVI), researchers from UK and Germany find in 2 separate studies. “These findings are clinically significant, as improvement in both quality and quantity of life is important to patients and physicians,” Dr. John P. Greenwood from -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/quality-of-life-improves-after-transcatheter-aortic-valve-implantation/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120511clin009.jpg"/>
	<media:keywords><![CDATA[TAVI,transcatheter aortic valve implantation]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Outcomes similar with on-pump or off-pump CABG in elderly patients</title>
		<link>http://www.thedoctorschannel.com/view/outcomes-similar-with-on-pump-or-off-pump-cabg-in-elderly-patients-2/</link>
		<pubDate>Tue, 08 May 2012 22:21:26 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[CABG]]></category>
		<category><![CDATA[elderly]]></category>
		<category><![CDATA[pump]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31269</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant difference in outcomes between on-pump and off-pump procedures in this population. “Both techniques are relatively safe and can be performed with a fairly low rate of major -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Outcomes similar with on-pump or off-pump CABG in elderly patients]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Despite the supposed advantage of off-pump coronary artery bypass grafting for elderly patients with ischemic heart disease, a Danish study found no significant difference in outcomes between on-pump and off-pump procedures in this population. “Both techniques are relatively safe and can be performed with a fairly low rate of major -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/outcomes-similar-with-on-pump-or-off-pump-cabg-in-elderly-patients-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120508clin001.jpg"/>
	<media:keywords><![CDATA[CABG,elderly,pump]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>New meta-analysis confirms benefits of radial approach for PCI</title>
		<link>http://www.thedoctorschannel.com/view/new-meta-analysis-confirms-benefits-of-radial-approach-for-pci/</link>
		<pubDate>Mon, 07 May 2012 22:26:59 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[PCI]]></category>
		<category><![CDATA[transfemoral]]></category>
		<category><![CDATA[transradial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31088</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the transfemoral approach, a new systematic review and meta-analysis of relevant research confirms. In addition, a benefit of the transradial approach on the incidence of death or myocardial -]]></description>
		
			<media:content duration="1:32" medium="video">
		<media:title><![CDATA[New meta-analysis confirms benefits of radial approach for PCI]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Percutaneous coronary intervention (PCI) performed via the transradial approach is less apt to cause bleeding and transfusions compared with PCI performed via the transfemoral approach, a new systematic review and meta-analysis of relevant research confirms. In addition, a benefit of the transradial approach on the incidence of death or myocardial -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/new-meta-analysis-confirms-benefits-of-radial-approach-for-pci/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120507clin001.jpg"/>
	<media:keywords><![CDATA[PCI,transfemoral,transradial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Pharmacodynamic study hints at optimal prasugrel reloading dose before PCI</title>
		<link>http://www.thedoctorschannel.com/view/pharmacodynamic-study-hints-at-optimal-prasugrel-reloading-dose-before-pci-2/</link>
		<pubDate>Thu, 03 May 2012 19:56:26 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[PCI]]></category>
		<category><![CDATA[Prasugrel]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30854</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – For patients on maintenance prasugrel (Effient) therapy having percutaneous coronary intervention (PCI), a dose of 60 mg in the peri-PCI period achieves “faster and higher” platelet inhibition compared to lower doses, according to results of a randomized open-label pharmacodynamic study published May 8 in the Journal of the American College -]]></description>
		
			<media:content duration="1:35" medium="video">
		<media:title><![CDATA[Pharmacodynamic study hints at optimal prasugrel reloading dose before PCI]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – For patients on maintenance prasugrel (Effient) therapy having percutaneous coronary intervention (PCI), a dose of 60 mg in the peri-PCI period achieves “faster and higher” platelet inhibition compared to lower doses, according to results of a randomized open-label pharmacodynamic study published May 8 in the Journal of the American College -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/pharmacodynamic-study-hints-at-optimal-prasugrel-reloading-dose-before-pci-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120503drgd001.jpg"/>
	<media:keywords><![CDATA[PCI,Prasugrel]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Higher late reinfarction rate seen with drug-eluting stents in primary PCI</title>
		<link>http://www.thedoctorschannel.com/view/higher-late-reinfarction-rate-seen-with-drug-eluting-stents-in-primary-pci-2/</link>
		<pubDate>Wed, 25 Apr 2012 21:51:09 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[bare-metal stents]]></category>
		<category><![CDATA[BMS]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[Drug-Eluting Stents]]></category>
		<category><![CDATA[reinfarction]]></category>
		<category><![CDATA[thrombosis]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30208</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In the setting of primary percutaneous coronary intervention for ST segment-elevated MI, use of drug-eluting stents (DES) rather bare metal stents (BMS) is associated with reduced long-term need for target vessel revascularization without significant differences in mortality, according to the results of a new meta-analysis. “However, DES implantation was associated -]]></description>
		
			<media:content duration="1:42" medium="video">
		<media:title><![CDATA[Higher late reinfarction rate seen with drug-eluting stents in primary PCI]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In the setting of primary percutaneous coronary intervention for ST segment-elevated MI, use of drug-eluting stents (DES) rather bare metal stents (BMS) is associated with reduced long-term need for target vessel revascularization without significant differences in mortality, according to the results of a new meta-analysis. “However, DES implantation was associated -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/higher-late-reinfarction-rate-seen-with-drug-eluting-stents-in-primary-pci-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120425drgd006.jpg"/>
	<media:keywords><![CDATA[bare-metal stents,BMS,DES,Drug-Eluting Stents,reinfarction,thrombosis]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Drug-eluting angioplasty balloon no advantage in primary PCI</title>
		<link>http://www.thedoctorschannel.com/view/drug-eluting-angioplasty-balloon-no-advantage-in-primary-pci/</link>
		<pubDate>Wed, 18 Apr 2012 21:07:27 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Drug-eluting angioplasty balloon]]></category>
		<category><![CDATA[PCI]]></category>
		<category><![CDATA[STEMI]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28348</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – In patients with ST-segment elevation MI undergoing percutaneous coronary intervention, dilatation with the DIOR drug-eluting balloon (DEB) before implantation of a bare metal stent does not improve outcomes. That’s according to the results of the DEB-AMI trial reported in the June 19/26 issue of the Journal of the American College -]]></description>
		
			<media:content duration="1:38" medium="video">
		<media:title><![CDATA[Drug-eluting angioplasty balloon no advantage in primary PCI]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – In patients with ST-segment elevation MI undergoing percutaneous coronary intervention, dilatation with the DIOR drug-eluting balloon (DEB) before implantation of a bare metal stent does not improve outcomes. That’s according to the results of the DEB-AMI trial reported in the June 19/26 issue of the Journal of the American College -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/drug-eluting-angioplasty-balloon-no-advantage-in-primary-pci/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120418drgd002.jpg"/>
	<media:keywords><![CDATA[Drug-eluting angioplasty balloon,PCI,STEMI]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Warfarin provides sufficient anticoagulation during PCI: study</title>
		<link>http://www.thedoctorschannel.com/view/warfarin-provides-sufficient-anticoagulation-during-pci-study/</link>
		<pubDate>Mon, 16 Apr 2012 20:49:10 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[heparin]]></category>
		<category><![CDATA[PCI]]></category>
		<category><![CDATA[warfarin]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28203</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Therapeutic oral anticoagulation with warfarin, without extra heparins, provides sufficient anticoagulation for patients on long-term warfarin who need primary percutaneous coronary intervention (PCI), cardiologists from Finland have found. They’ve found that additional heparins are not necessary and may only increase complications. In an email to Reuters Health, Dr. Kari Eino -]]></description>
		
			<media:content duration="1:29" medium="video">
		<media:title><![CDATA[Warfarin provides sufficient anticoagulation during PCI: study]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Therapeutic oral anticoagulation with warfarin, without extra heparins, provides sufficient anticoagulation for patients on long-term warfarin who need primary percutaneous coronary intervention (PCI), cardiologists from Finland have found. They’ve found that additional heparins are not necessary and may only increase complications. In an email to Reuters Health, Dr. Kari Eino -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/warfarin-provides-sufficient-anticoagulation-during-pci-study/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120416clin001.jpg"/>
	<media:keywords><![CDATA[heparin,PCI,warfarin]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>PCI outcomes in AF patients similar with different stent types</title>
		<link>http://www.thedoctorschannel.com/view/pci-outcomes-in-af-patients-similar-with-different-stent-types/</link>
		<pubDate>Wed, 11 Apr 2012 02:29:00 +0000</pubDate> 
				<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[Cardiology: Interventional]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[AF]]></category>
		<category><![CDATA[atrial fibrillation]]></category>
		<category><![CDATA[bare metal stent]]></category>
		<category><![CDATA[BMS]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[drug-eluting stent]]></category>
		<category><![CDATA[PCI]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27924</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing percutaneous coronary intervention, adverse event rates are similar with either drug-eluting stents (DESs) or bare metal stents (BMSs), according to a report in the American Journal of Cardiology online March 29. “In our cohort, systematic use of DESs does not seem to be justified -]]></description>
		
			<media:content duration="1:19" medium="video">
		<media:title><![CDATA[PCI outcomes in AF patients similar with different stent types]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing percutaneous coronary intervention, adverse event rates are similar with either drug-eluting stents (DESs) or bare metal stents (BMSs), according to a report in the American Journal of Cardiology online March 29. “In our cohort, systematic use of DESs does not seem to be justified -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/pci-outcomes-in-af-patients-similar-with-different-stent-types/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120410drgd002.jpg"/>
	<media:keywords><![CDATA[AF,atrial fibrillation,bare metal stent,BMS,DES,drug-eluting stent,PCI]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
